CPAP vs Inspire: Understanding Your Treatment Options

CPAP (Continuous Positive Airway Pressure) is the most commonly prescribed treatment for obstructive sleep apnea. A bedside machine delivers pressurized air through a tube and mask worn over the nose or mouth during sleep. The continuous airflow creates positive pressure in the airway that physically prevents the airway from collapsing during sleep.

CPAP is highly effective when used correctly and consistently — but real-world compliance is a persistent challenge. Research suggests that 30–50% of patients either cannot tolerate CPAP or abandon it within the first year of treatment.

Inspire is an FDA-approved upper airway stimulation system — a small implantable device surgically placed during a procedure performed under general anesthesia. The system monitors breathing throughout the night and delivers mild electrical stimulation to the hypoglossal nerve, which controls tongue movement, to prevent airway collapse.

Inspire is specifically approved for moderate to severe obstructive sleep apnea patients who cannot achieve benefit from CPAP and who meet specific anatomical eligibility criteria confirmed through a specialized evaluation called a drug-induced sleep endoscopy (DISE).

The two treatments take fundamentally different approaches to keeping the airway open during sleep.

Both CPAP and Inspire are clinically proven to significantly reduce obstructive sleep apnea events. In clinical trials, Inspire reduced the median AHI (apnea-hypopnea index) by approximately 79% at 12 months in eligible patients.

CPAP, when used consistently, can reduce AHI to near-zero levels — but the critical caveat is consistent use. Because CPAP compliance is frequently poor in real-world settings, Inspire may produce better sustained outcomes for patients who have been unable to adhere to CPAP therapy.

CPAP compliance is the most significant limitation of the therapy. Mask discomfort, air leaks, machine noise, dry mouth, claustrophobia, and travel inconvenience are among the most frequently cited reasons for abandoning CPAP.

Inspire eliminates the mask and machine entirely. After recovery from surgery, the device operates silently and invisibly — the patient simply activates it with a remote before bed. Most patients report that the device is not noticeable during sleep or daily activity.

For patients who have struggled with CPAP compliance, Inspire can be a significant quality-of-life improvement — provided they meet the eligibility criteria and are prepared for a surgical procedure. Patients who wish to avoid surgery entirely may also be good candidates for oral appliance therapy. See our Oral Appliance vs CPAP and Oral Appliance vs Inspire comparison pages for more detail.

Day-to-day life looks very different with each treatment.

CPAP is relatively low cost — machines typically range from a few hundred to around $1,000 — and are covered by most insurance plans with a sleep apnea diagnosis.

Inspire is a surgical procedure with costs that often exceed $30,000 before insurance. It is covered by Medicare and many private insurers for patients who meet strict eligibility criteria. Patients should confirm coverage and prior authorization requirements before proceeding.

Inspire has specific FDA eligibility requirements. Patients must meet all of the following:

CPAP remains the first-line prescribed treatment for many patients — particularly those newly diagnosed who have not yet attempted therapy. For patients who can achieve and maintain comfortable CPAP use, it provides highly effective AHI reduction with broad insurance coverage and no surgical risk.

Patients who struggle with CPAP should speak with both a physician and a Sleep Apnea Dentist Houston specialist about alternatives — including oral appliance therapy — before pursuing a surgical option like Inspire. Oral appliance therapy is an effective, non-surgical bridge for many patients who fall between CPAP compliance and surgical candidacy.